TG Therapeutics Inc (NASDAQ:TGTX)

5.56
Delayed Data
As of Oct 22
 +0.04 / +0.72%
Today’s Change
3.32
Today|||52-Week Range
9.38
+35.61%
Year-to-Date

Stock Price Forecast

The 4 analysts offering 12-month price forecasts for TG Therapeutics Inc have a median target of 18.50, with a high estimate of 39.00 and a low estimate of 12.00. The median estimate represents a +232.73% increase from the last price of 5.56.

Analyst Recommendations

The current consensus among 4 polled investment analysts is to Buy stock in TG Therapeutics Inc. This rating has held steady since September, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.35
Sales
$35.7K
Reporting Date
Nov 06

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 17.86%
 
 
 
 
 
 
Growthannually 32.93%
 
 
 
 
 
 

Sales

Growthquarterly -6.14%
 
 
 
 
 
 
Growthannually 0.88%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.